Drug Database
AB

abacavir sulfate

✓ Approved

Roche · 辅助诊断 · 辅助诊断

什么是 abacavir sulfate?

abacavir sulfate 是一种辅助诊断,由Roche研发。该药已获批,用于治疗相关适应症,给药途径:Others。

药物档案

公司Roche
药物类别辅助诊断
给药途径Others
状态Approved

相关研究文献

PubMedFrontiers in public health2026-11-17

Constructing the Self Data Atlas ontology: a crisp-fuzzy ontology for quality of life representation in children with neurodevelopmental and learning disabilities.

Snead R Sterling RS

The lived experiences of children with neurodevelopmental and learning disabilities are documented through diverse forms of personal data, including identity, medical, mental health, accomplishments, social relationships, financial resources, and personal ecology. However, these records rarely integrate quality of life (QoL) information represented through validated multidimensional frameworks. Building on the gap identified in a companion narrative review, this paper presents a reproducible ontology engineering methodology for representing QoL in children with neurodevelopmental and learning disabilities. The paper presents a design-science methodology for constructing an ontology from the Self Research Institute's Self Data Atlas (SDA), a seven-category taxonomy for organizing longitudinal personal data. Derived from Wieringa's design-science framework, the methodology follows a seven-step protocol comprising: (1) competency-question-based requirements specification; (2) ontology reuse and re-engineering; (3) conceptualization; (4) crisp formalization in OWL 2 DL; (5) fuzzy formalization in Fuzzy OWL 2; (6) alignment with the Common Core Ontology (CCO) as a Basic Formal Ontology (BFO)-conformant mid-level scaffold; and (7) iterative evaluation and refinement. The methodology incorporates two complementary design features. First, it separates factual and classificatory information, including demographics, SNOMED CT diagnostic codes, and clinical observations, represented in classical description logic, from graded and context-dependent QoL concepts, including social inclusion, severity, intensity, and wellbeing, represented using fuzzy datatypes, fuzzy linguistic variables, and graded class membership. Second, it embeds tritemporal reasoning by assigning three temporal qualifiers to each SDA event, state, or information artifact: (1) absolute time, representing when the fact existed in reality; (2) ingestion time, representing when the record entered the system; and (3) assignment time, representing when an interpretative classification was applied. These temporal qualifiers are represented as ontology entities rather than opaque metadata. This tritemporal structure supports longitudinal queries, retrospective recording, and event-history replay. Each stage is illustrated using examples from the seven SDA categories. The paper illustrates how CCO classes provide stable upper-level abstractions for SDA components and interoperability with ICF, SNOMED CT, HL7 FHIR, and the Schalock-Verdugo QoL model. This paper makes a methodological rather than an empirical contribution. It provides a reproducible ontology engineering methodology for future SDA ontology development and related personal-data ontologies.

PMID 43041417
阅读全文 →
PubMedHCA healthcare journal of medicine2026-11-17

Making Diagnostic Uncertainty Visible at Intensive Care Unit Transitions: A Narrative Review of Diagnostic Pause Strategies.

West Raha R, ElHaddad Ahmed A, Baharlo Behrad B, Patel Parind P

Diagnostic error is a significant patient safety issue in critical care. However, it is often difficult to detect during ongoing care. Patients in the Intensive Care Unit (ICU) often have incomplete histories, overlapping symptoms, changing physiology, and concurrent issues. During ICU transitions, patient diagnoses are often reported without clear information on diagnostic confidence, potential alternative diagnoses, pending results, or triggers needing review. This clinical narrative review explored diagnostic uncertainty at ICU transitions, specifically those during ICU-to-ward transfers or unplanned escalations to the ICU. A targeted literature search identified studies of adult ICU diagnostic errors, ICU transition safety, ICU-PAUSE and diagnostic-pause literature, pediatric critical care diagnostic timeouts, and broader diagnostic safety reviews. A narrative approach was selected because the evidence was diverse and not suitable for meta-analysis. The literature indicates that diagnostic discrepancies occur in the ICU, that ICU transfers are high-risk periods for adverse events and communication failures, and that diagnostic-pause tools may help make uncertainty more visible. Although clinical outcome evidence remains limited, the safety rationale is strong. A brief diagnostic pause can help ICU teams make diagnostic uncertainty explicit by asking: What is the working diagnosis? How certain are we? What else could be possible? What is still pending? What should prompt re-evaluation? Who owns the follow-up? Making these points explicit may support safer handovers, clearer follow-up and earlier diagnostic review after ICU transitions.

PMID 43042407
阅读全文 →
PubMedBeilstein journal of organic chemistry2026-11-17

Sulfated prism[6]arene binds one guest internally and one guest externally.

Bazan-Bergamino Emmanuel A EA, Ayoub Steven S, Mobley David L DL, Isaacs Lyle L

We report the synthesis of sulfated prism[6]arene (Pr[6]AS) by reaction of (HO)12Pr[6] with SO3·pyridine in 35% yield. Pr[6]AS has very good solubility in water (>30 mM) and does not undergo self-association according to 1H NMR dilution experiments. Qualitative 1H NMR investigations show that guest resonances shift dramatically upfield and become significantly broadened upon complexation with Pr[6]AS. Isothermal titration calorimetry (ITC) experiments show that Pr[6]AS forms ternary complexes (Pr[6]AS·guest2) with hydrophobic ammonium ions in phosphate buffered saline with β-values (K a1 × K a2) values up to 6.84 × 1013 M-2. Molecular dynamics simulations show that Pr[6]AS firmly binds one guest (6q, Me4Bipip) within its cavity and a second guest (6q, Me4Bipip) on the convex region of Pr[6]AS in close proximity to the externally directed sulfate substituents. Uncomplexed Pr[6]AS holds 7.6 ± 1.9 H2O and one Na+ ion within its cavity. Formation of the 1:1 and 1:2 Pr[6]AS-6q complexes results in expulsion of the Na+ ion and approximately five of the solvating H2O molecules. Intriguingly, the combination of larger naphthalene walls and sulfate ionic groups that are conformationally restricted creates a secondary guest binding site on the exterior of Pr[6]AS which suggests a route toward the design of high molecularity complexes.

PMID 43041819
阅读全文 →
PubMedThe Journal of clinical and aesthetic dermatology2026-11-17

Erosion of Clinicopathologic Correlation in the Diagnosis of Pigmented Skin Lesions: Electronic Medical Record Artifacts, Diagnostic Inflation, and Downstream Consequences.

Obagi Sabine S, Cockerell Clay J CJ

To evaluate the clinical utility and diagnostic concordance of the designation "rule out melanoma" (ROM) in dermatopathology requisitions and to assess its potential contribution to diagnostic inflation. An observational analysis was conducted of 13,000 dermatopathology requisition forms submitted between January 1 and July 1, 2025, in which ROM was listed as the primary or sole clinical diagnosis. Concordance between clinical designation and histopathologic diagnosis was assessed. Of 13,000 cases, 1,196 (9.2%) were diagnosed as melanoma (invasive or melanoma in situ). The remaining 11,804 cases (90.8%) represented nonmelanoma diagnoses, most commonly solar lentigo, seborrheic keratosis, melanocytic nevi (including dysplastic nevi), pigmented actinic keratosis, and pigmented basal cell carcinoma. This analysis represents a single-institution observational dataset. The ROM designation demonstrates low positive predictive value and provides limited actionable diagnostic information. These findings suggest that current clinical labeling practices may contribute to reduced diagnostic specificity and broader patterns of diagnostic inflation.

PMID 43042111
阅读全文 →
PubMedJournal of pediatric gastroenterology and nutrition2026-11-17

Genetic testing strategies for neonatal cholestasis in the neonatal intensive care unit.

Lakhani Alyshah A, Joshi Shivam S, Balster Sarah S, Weymann Alexander A et al.

Cholestasis in the Neonatal Intensive Care Unit (NICU) has a broad differential diagnosis, including genetic diseases. Advances in next generation sequencing (NGS) have expanded the ability to identify genetic etiologies. Studies evaluating testing strategies, diagnostic yield, and clinical characteristics of those undergoing genetic testing for cholestasis in the NICU are limited. We retrospectively studied patients at a single-center Level IV NICU with cholestasis, genetic testing and Hepatology consultation between January 1, 2015, and December 31, 2024. Microarray, targeted gene panel and exome or genome sequencing (ES/GS) results and clinical characteristics of those tested were reviewed. Diagnostic yield was defined as identification of pathogenic variants determined to be causative of cholestasis. Categorical variables were compared using Chi-squared test or Fisher's exact as appropriate. Continuous variables were compared using Wilcoxon rank sum tests or Kruskal-Wallis tests as appropriate. A total of 174 patients were included for analysis. Patients with three modalities of testing had higher peak direct bilirubin and alanine aminotransferase. Diagnostic yield increased by comprehensiveness: microarray 5% (3/54), targeted gene panel 10% (12/125) and ES/GS 33% (23/70). Seven patients with non-diagnostic targeted panels had diagnostic ES/GS. Those with diagnostic ES/GS were younger at Hepatology consultation, had higher peak direct bilirubin and were less likely to have sepsis compared to those with diagnostic targeted panels. ES/GS demonstrated greater diagnostic yield for cholestasis in the NICU than other modalities. Confounding by year of testing is possible, but differences in yield support preferential use of ES/GS for neonatal cholestasis evaluation.

PMID 43042718
阅读全文 →
PubMedFrontiers in medicine2026-11-17

Diagnostic spectrum and cytomorphological features of 1,641 pancreatobiliary EUS-FNA specimens: a five-year retrospective study from a central cytopathology laboratory serving 14 hospitals.

Elmas Hatice H, Kholová Ivana I, Ergüven Fatih Baybars FB, Welker Lutz L

Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a well-established minimally invasive method for evaluating pancreatic and biliary tract lesions. Cytological assessment of EUS-FNA samples provides information on the heterogeneous spectrum of pancreatobiliary diseases. This study aimed to describe the real-world diagnostic spectrum, cytomorphological characteristics, specimen adequacy, and distribution of cytological diagnostic categories in pancreatobiliary EUS-FNA specimens obtained in routine clinical practice. This retrospective real-world diagnostic spectrum study analyzed 1,641 EUS-FNA specimens obtained from pancreatic and biliary tract lesions between January 2021 and November 2025. Specimens were obtained from EUS-FNA procedures performed at 14 referring hospitals across Germany and interpreted at a single central reference cytopathology laboratory. Specimens were processed using conventional May-Grünwald-Giemsa and Papanicolaou staining, and cytological diagnoses were categorized following systematic cytomorphological evaluation with integration of available clinical and radiological information. The primary study outcomes were the distribution of cytological diagnoses, specimen adequacy, non-diagnostic rates, and the cytomorphological spectrum of pancreatobiliary lesions. Because systematic histopathological or long-term clinical reference-standard follow-up was not available for the entire cohort, formal diagnostic performance analyses were not performed. Definitive cytological diagnoses were obtained in 503 cases (30.7%). Non-diagnostic specimens accounted for 133 of 1,641 cases (8.1%), corresponding to a diagnostic yield of 91.9% (1,508/1,641) when all other categories were counted as clinically informative. Pancreatic ductal adenocarcinoma was the most common diagnosis (n = 291; 17.7%), followed by pancreatic neuroendocrine neoplasms (n = 51; 3.1%), neuroendocrine carcinoma (n = 11; 0.7%), acinar cell carcinoma (n = 10; 0.6%), solid pseudopapillary neoplasm (n = 6; 0.4%), adenosquamous carcinoma (n = 2; 0.1%), and mucinous neoplasms including cystadenocarcinoma (n = 1; 0.1%). Benign and premalignant cystic lesions included pseudocysts (n = 79; 4.8%), intraductal papillary mucinous neoplasms (n = 36; 2.2%), and serous cystadenomas (n = 3; 0.2%). Other findings comprised metastatic tumors (n = 34; 2.1%), malignant tumors not otherwise specified (n = 47; 2.9%), suspicious for malignancy (n = 115; 7.0%), inflammatory lesions (n = 149; 9.1%), negative/normal cytology (n = 558; 34.0%), and non-diagnostic samples (n = 133; 8.1%). EUS-FNA cytology provides clinically relevant information across a wide range of pancreatic and biliary tract lesions. This large, real-world cohort delineates the contemporary diagnostic spectrum of pancreatobiliary EUS-FNA cytology encountered in routine clinical practice and provides reference data on the distribution of cytological diagnostic categories, with a supplementary reclassification according to the WHO International System for Reporting Pancreaticobiliary Cytopathology. These data may serve as reference values for institutional quality assurance, including the monitoring of diagnostic yield and non-diagnostic rates.

PMID 43041262
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多abacavir sulfate